{"transactions":[{"id":1863592,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2023-06-08T01:24:37.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":1057,"price":37.865,"value":40023.305,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":38115,"source":{"system":"sec-edgar","filing":"0001209191-23-035258","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123035258/doc4.xml","form_type":"4"}},{"id":1863591,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2023-06-08T01:24:37.000Z","date":"2023-06-06","kind":"sale","planned":false,"acquired":false,"shares":1014,"price":38.991,"value":39536.874,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 416 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022 and December 2022."}],"balance_after":39172,"source":{"system":"sec-edgar","filing":"0001209191-23-035258","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123035258/doc4.xml","form_type":"4"}},{"id":2238741,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T23:31:47.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":19900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":19900,"derivative":{"exercise_price":59.39,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":19900},"source":{"system":"sec-edgar","filing":"0001209191-22-035225","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035225/doc4.xml","form_type":"4"}},{"id":2238740,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2022-06-08T23:31:47.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":7950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":39770,"source":{"system":"sec-edgar","filing":"0001209191-22-035225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035225/doc4.xml","form_type":"4"}},{"id":2238739,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2022-06-08T23:31:47.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":2140,"price":61.374,"value":131340.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 258 and 161 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021 and December 2021, respectively."}],"balance_after":31820,"source":{"system":"sec-edgar","filing":"0001209191-22-035225","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035225/doc4.xml","form_type":"4"}},{"id":2671410,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-12T00:48:23.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":15000,"derivative":{"exercise_price":60.96,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-040098","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121040098/doc4.xml","form_type":"4"}},{"id":2671409,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2021-06-12T00:48:23.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":33541,"source":{"system":"sec-edgar","filing":"0001209191-21-040098","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121040098/doc4.xml","form_type":"4"}},{"id":2677108,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2021-06-08T20:15:38.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":1895,"price":61.037,"value":115665.115,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 355 and 183 shares of common stock acquired under the issuer's employee stock purchase plan in June 2020 and December 2020, respectively."}],"balance_after":27541,"source":{"system":"sec-edgar","filing":"0001209191-21-038884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121038884/doc4.xml","form_type":"4"}},{"id":3113031,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T22:31:10.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":47.65,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-036047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120036047/doc4.xml","form_type":"4"}},{"id":3113030,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-06-11T22:31:10.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2021, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":28898,"source":{"system":"sec-edgar","filing":"0001209191-20-036047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120036047/doc4.xml","form_type":"4"}},{"id":3118202,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-06-09T01:07:20.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":1447,"price":46.331,"value":67040.957,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 229 shares of common stock acquired under the issuer's employee stock purchase plan in December 2019."}],"balance_after":14898,"source":{"system":"sec-edgar","filing":"0001209191-20-035172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120035172/doc4.xml","form_type":"4"}},{"id":3336359,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-12-18T23:54:04.000Z","date":"2019-12-16","kind":"sale","acquired":false,"shares":3671,"price":45.7935,"value":168107.9385,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.73 to $45.81, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 365 shares of common stock acquired under the issuer's employee stock purchase plan in June 2019."}],"balance_after":16116,"source":{"system":"sec-edgar","filing":"0001209191-19-061186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119061186/doc4.xml","form_type":"4"}},{"id":3498494,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T20:50:17.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":33800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":33800,"derivative":{"exercise_price":43.54,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":33800},"source":{"system":"sec-edgar","filing":"0001209191-19-035115","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119035115/doc4.xml","form_type":"4"}},{"id":3498493,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-06-06T20:50:17.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":5600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2020, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":19422,"source":{"system":"sec-edgar","filing":"0001209191-19-035115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119035115/doc4.xml","form_type":"4"}},{"id":3498492,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-06-06T20:50:17.000Z","date":"2019-06-04","kind":"sale","acquired":false,"shares":1099,"price":42.91,"value":47158.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 88 shares of common stock acquired under the issuer's employee stock purchase plan in December 2018."}],"balance_after":13822,"source":{"system":"sec-edgar","filing":"0001209191-19-035115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119035115/doc4.xml","form_type":"4"}},{"id":3821734,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":112610,"kind":"person","name":"McLoughlin Dennis","position":1,"cik":"0001752004","reported_name":"McLoughlin Dennis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-07T21:00:47.000Z","date":"2018-09-05","kind":"exercise","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the option shares on August 29, 2019, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":46.55,"expiration_date":"2028-08-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-050102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919118050102/doc4.xml","form_type":"4"}}]}